Anti-H3N2 subtype canine influenza virus nucleoprotein monoclonal antibody hybridoma 2D10, and monoclonal antibody
A technology of H3N2-CIV-NP-2D10, monoclonal antibody, applied in the field of immunology, can solve problems such as influenza pandemic, achieve the effect of high specificity and sensitivity, and high secretion yield
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0019] The present invention will be further described below in conjunction with specific experiments, but not limited thereto.
[0020] Establishment of H3N2-CIV-NP-2D10 hybridoma cell line and preparation and identification of anti-H3N2 subtype canine influenza virus NP monoclonal antibody
[0021] 1. Immunization of mice
[0022] The inactivated H3N2 subtype canine influenza virus was mixed with an equal volume of complete Freund's adjuvant, and then injected subcutaneously into the back of BALB / C mice at multiple points in the amount of 50 μg / 500 μl each (Experimental Animal Center of Southern Medical University , 6-8 weeks old female, 3) for the first immunization; 2 weeks later, the adjuvant was replaced with Freund's incomplete adjuvant for the second routine immunization, the immunization method and dose were the same as the first immunization; a small amount was collected after three routine immunizations Tail vein blood, serum titer was detected by indirect ELISA. ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com